Cullinan Associates’s Insulet PODD Stock Holding History
Bought
Maintained
Sold
Other funds holding PODD
Cullinan Associates's PODD Position: Q3 2026 in Review
Cullinan Associates increased its Insulet (PODD) stake by 2.2% in Q3 2026, buying an estimated $8.08K and bringing the position to 2,554 shares worth $333K. The position accounts for 0.03% of the portfolio, ranked #182.
Cullinan Associates first reported a position in PODD in Q1 2026 and has held it in 3 quarters since. The position peaked at $525K in Q1 2026. 626 funds tracked by Wall St. Rank hold PODD as of Q3 2026.
- Cullinan Associates held 2,554 shares of Insulet worth $333K as of Q3 2026.
- Cullinan Associates bought 54 Insulet shares in Q3 2026, an estimated $8.08K.
- Insulet made up 0.03% of Cullinan Associates's portfolio in Q3 2026, its #182 holding.
- Cullinan Associates first reported a position in Insulet in Q1 2026 and has held it in 3 quarters since.
- Cullinan Associates's Insulet position peaked at $525K in Q1 2026.
- 626 funds tracked by Wall St. Rank held Insulet as of Q3 2026.
Based on Cullinan Associates's 13F filing for Q3 2026, filed 3 Nov 2026.